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Morphological retinal changes combined with functional evidence implicate hypoxia 
in the pathogenesis of age-related macular degeneration (AMD). However, the role 
of hypoxia in the scotopic threshold deficit reported in AMD has not been 
investigated. This study compared scotopic thresholds in participants with early and 
intermediate AMD recorded under conditions of systemic hypoxia, hyperoxia and 
normoxia. 
 
Materials and Methods 
Over two sessions scotopic thresholds were measured with participants breathing 
21% and 60% oxygen (n= 12 early AMD, n= 11 age-similar controls) or 21% and 14% 
oxygen (n=16 early AMD, n=20 age-similar controls). Thresholds were measured 
using a ‘white’, annular 12 degrees stimulus, using a QUEST procedure.   
 
Results 
There was no statistically significant change in scotopic thresholds within the AMD or 
control group when breathing the hyperoxic gas mixture (60% oxygen) or the 
hypoxic gas mixture (14% oxygen) when compared to the normoxic condition (21% 
oxygen). There was also no statistically significant difference in scotopic thresholds 
between groups under the hyperoxic or hypoxic gas conditions. The difference 
between groups under the normoxic condition was not statistically significant for the 
hyperoxia study (p= 0.70), but did reach significance in the hypoxia study (p=0.05). 
Conclusion 
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This study provided no evidence that breathing that breathing 14% or 60% oxygen 
altered scotopic thresholds in those with early AMD when compared to controls. 
However, the lack of elevated scotopic thresholds in the AMD group of the hyperoxia 
study is of note, as it is unlikely that hyperoxia would reduce thresholds which were 
not significantly raised at baseline, regardless of whether hypoxia was a factor in the 
disease pathogenesis. The findings of this study do not rule out a role for hypoxia in 
early AMD, but this needs to be assessed in future experiments using measures that 
differ significantly between people with AMD and controls. 
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Age-related macular degeneration (AMD) is a disease characterised by progressive 
central vision loss due to photoreceptor degeneration at the macula. It is the leading 
cause of certified visual loss in the UK 1 and is predicted to affect 196 million people 
globally by 2020 2. 
The pathogenesis of AMD remains elusive but oxidative stress 3,4, inflammation 5, and 
hypoxia 6,7 have all been implicated. Morphological changes to the retina and 
associated structures implicate hypoxia in the disease process. For example, changes 
to the choroid seen in AMD include a decreased choroidal blood flow 8, choriocapillaris 
drop out 9, and changes in choroidal vascularity index 10. A reduced choroidal blood 
supply might be associated with a reduced oxygen supply to the outer retina, 
especially in view of animal studies suggesting that the oxygen supply is only just 
sufficient to meet the needs of the photoreceptors under dark adapted conditions 11. 
In addition, age related thickening of Bruch’s membrane 12 and the formation of basal 
linear deposits associated with AMD 13,14, increase the distance over which oxygen 
must diffuse to reach the retina from the choroidal circulation. According to Fick’s law, 
this results in a reduction in the diffusion flux 7, which may also impact on oxygen 
availability at the outer retina. Immunohistochemical studies have found increased 
levels of VEGF in early AMD 15, lending support to the notion that the hypoxia is a 
feature of early AMD. However, it should be noted that a range of other factors may 
also lead to elevated levels of VEGF, including inflammation, acidosis, and other 
growth factors, such as TGF-α,TGF-β, insulin-like growth factor-1, FGF and platelet-
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derived growth factor 16,17. VEGF up-regulation alone is not, therefore, a strong 
indicator of the presence of hypoxia. 
There is also circumstantial evidence to suggest that hypoxia may affect visual function 
in AMD. Visual deficits have been reported early in the disease process with colour 
vision 18,19, contrast sensitivity 20, dark adaptation 21, and scotopic thresholds 22 all 
altered in early AMD. These same functions are also reduced in a comparable way in 
normal participants experiencing a hypoxic episode 23-27, suggesting that hypoxia 
could contribute to the dysfunction seen in AMD. There is evidence from prior studies 
that systemic hyperoxia may overcome deficits in retinal function in diabetic 
retinopathy 28-29, but this has not been investigated in AMD. 
Despite the anatomical and functional evidence implicating hypoxia in the 
pathogenesis of AMD, the relationship between abnormal visual function and hypoxia 
in AMD has not yet been investigated. This study aimed to address this by comparing 
scotopic thresholds in participants with early AMD recorded under conditions of 
systemic hyperoxia, hypoxia and normoxia. The hypotheses were as follows 
 If hypoxia were responsible for the elevated scotopic thresholds associated 
with early AMD, breathing oxygen enriched air would result in a selective 
reduction in scotopic thresholds in people with AMD.  
 If hypoxia were responsible for the elevated scotopic thresholds associated 
with early AMD, breathing oxygen diminished air would result in a selective 
rise in scotopic thresholds in people with AMD, which would be greater than 
that observed in healthy controls.  
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Materials and Methods 
Participants 
All participants were recruited from patients attending the University Hospital Wales 
Ophthalmology outpatients’ clinic and Cardiff University Eye Clinic, or directly from 
local optometrists in the South Wales area. All participants were aged 55 years or 
older with a corrected visual acuity of 6/12 or better, a refractive error of < 6.00 DS in 
the most powerful meridian, and clear ocular media in the test eye (less than grade 2 
on the LOCSIII grading scale 30 for all criteria). Exclusion criteria included: smoking, lung 
conditions, (such as emphysema), systemic health conditions or medication known to 
affect vision, or the presence of ocular disease other than AMD. Participants with a 
fundus appearance graded as early to intermediate AMD in one or both eyes (who had 
medium to large drusen with or without focal pigmentary changes) 31 were assigned 
to the AMD group. This group also contained patients who were being treated for 
neovascular AMD (nAMD) in the non-test eye who had no, or only early AMD in the 
test eye. The control group comprised age matched participants with no sign of AMD 
in both eyes 31. Written consent was obtained before participation and all procedures 
adhered to the tenets of the Declaration of Helsinki. The study was approved by South 
East Wales Research Ethics Committee (reference number 12/WA/0266). 
Apparatus and psychophysical methods  
All stimuli for the psychophysical studies were presented on a gamma corrected high-
resolution monitor (LS902UT, Liyama, Hoofddorp, Netherlands) driven by an 8-bit 
(Geforce 9, nVIDIA, Santa Clara, USA) graphics board under the control of MATLAB 
(Mathworks Inc, Natick, MA, USA). Scotopic thresholds were measured in response to 
 7 
a ‘white’, annular stimulus which had a radius of 12 degrees and a width of 0.5 
degrees. Stimulus threshold was determined using the QUEST Bayesian adaptive 
procedure 32 written with Psychophysics Toolbox extensions 33. The outputs of the 
program were scotopic threshold and its standard deviation. A pulse oximeter (Crucial 
Medical Systems CMS 50E) was used to monitor peripheral blood oxygen saturation 
(SpO2) in all experiments. Air was respired by the patient through a 60% ventimask 
(Intersurgical, Wokingham, UK) which mixes the contents of a gas cylinder in a 1:1 
ratio with ambient air. Hence, a cylinder containing 100% oxygen delivered 60% 
oxygen, medical air provided 21% oxygen and a canister containing 8% oxygen 
provided 14% oxygen for inspiration. 
Experimental design 
Baseline examinations including patient history, distance monocular logMAR visual 
acuity (Early Treatment Diabetic Retinopathy Study), visual field screening (SITA fast 
24-2, Humphrey Field Analyzer) and colour vision testing (desaturated D15) were 
completed at the start of the visit. All procedures involving bright lights being 
presented to the eyes (binocular indirect fundus examination, fundus photography, 
slit lamp examination and OCT) were carried out at the end of each visit, to avoid 
excessive photopigment bleaching before the measurement of dark-adapted retinal 
function. The fundus appearance of all participants was classified by Optometrist 
observer TC according to the Beckman Initiative grading scale (Ferris et al., 2013), and 
also assigned a risk factor for progression to advanced AMD according to the AREDS 
simplified scale 34, whereby individuals are assigned a risk point (up to a maximum of 
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4) for factors including the presence of large drusen in one or both eyes, the presence 
of pigmentary changes, and the presence of nAMD in the fellow eye. 
At the first visit, the effect of hyperoxia was assessed to address the first hypothesis. 
The timeline of the experiment is shown in Figure 1. After a one-hour period of dark 
adaption, each participant took part in two trial QUEST runs, each consisting of 20 
presentations. Participants proceeded to the main study only if the thresholds of both 
practice runs were within 1 standard deviation of one another. If this was not the case 
then a third practice run was undertaken, if this threshold was not within 1 standard 
deviation of the first two practice runs then the study was stopped at this point. 
The first of two randomly assigned gases, either medical air (control) or the 
experimental (hyperoxic) gas was then turned on. The participant was masked to 
which gas was being inhaled and the randomisation of the gas order was balanced so 
that the same number of individuals received each gas type first. The first gas was 
inhaled for 10 minutes and, within the last 5 minutes, scotopic threshold was 
determined. There then followed a 5-minute wash out period where no gas was given. 
The second of the two gases was then turned on for 10 minutes with the scotopic 
threshold recorded again within the final 5 minutes. The participant’s SpO2 was 
monitored throughout the duration of the experiment, and recorded at one-minute 
intervals with the experiment terminated if SpO2 dropped below 85%. 
[Location of Figure 1]    
Participants returned on a different day to take part in the evaluation of the effect of 
hypoxia. The timeline of the study was identical on the second visit, with the only 
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variation being the oxygen content of the experimental gas condition. All baseline 
tests were repeated to ensure correct classification. 
Statistical analysis 
There were no previous studies, to our knowledge, available to inform power 
calculations hence this was an exploratory randomized controlled trial. Distributional 
assumptions were tested using the Shapiro-Wilkes test. Paired t-tests (Wilcoxon 
signed rank test for non-normally distributed data) were carried out to determine 
whether SpO2 and scotopic thresholds were significantly different between gas 
conditions within each group. Independent samples t-tests (or Mann-Whitney U test 
as a non-parametric alternative) were carried out to determine whether SpO2 and 
scotopic thresholds differed significantly between controls and people with AMD 
under each gas condition, and also to compare change in threshold between gas 
conditions in people with and without AMD. In order to test for order effects, a paired 
t-test was used to compare scotopic thresholds between the gas presented first and 
second.  
Results  
All participants taking part in the first study, evaluating the effect of hyperoxia on 
scotopic thresholds were invited to take part in the second study to assess the effect 
of hypoxia, but the final cohort differed between studies. In the hyperoxic study 
there were 11 control participants (mean age 69 years ±6SD, 36% female), and 12 
individuals with AMD (mean age 74 years±6SD, 50% female). In the hypoxia study 
there were 20 control participants (mean age 68 years ±5SD, 40% female), and 16 
with AMD (mean age 73 years ±5SD, 38% female). There was no significant 
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difference in age between the AMD group and the control group for either study 
(p>0.05). The participant characteristics of the people with early and intermediate 
AMD are shown in Table 1. It is notable that 18 of the 22 participants had high risk 
AMD features in the fellow eye. One participant was excluded from the hypoxia 
study due to their SpO2 dropping below 85%.  One participant was excluded from the 
hypoxia study due to their SpO2 dropping below 85%.  Hence, data were collected 
from 35 participants in total for this study.  
[Location of Table 1] 
Hyperoxia and Scotopic thresholds 
SpO2 results  
Figure 2 (Panel A) shows the group mean SpO2 levels for the AMD and control 
participants, with confidence intervals across ten minutes. Statistical analysis for the 
last 5 minutes of the data confirmed that the difference in mean SpO2 readings 
between breathing 60% and 21% oxygen was significant in people with early AMD 
(Wilcoxon signed rank p < 0.01) and in the control group (Wilcoxon signed rank p < 
0.01). The median SpO2 (averaged over the last 5 minutes of breathing each gas type) 
under normoxic conditions was 98% (96.5% to 98%) in the participants with AMD, and 
97% (97% to 98%) in the control group. This difference, whilst small, was statistically 
significant (Mann-Whitney p<0.01). The median SpO2 under hyperoxic conditions was 
99% (99% to 99%) in the participants with AMD, and 99% (99% to 99%) in the control 
group. This did not differ significantly between the two groups (Mann-Whitney p = 
0.94).  
[Location of Figure 2] 
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Scotopic threshold results  
Scotopic threshold data were obtained for all participants. As an example, the output 
of the QUEST procedure is shown in Figure 3 panels a and c for a control participant 
alongside the SpO2 readings per minute over the 10 minutes of gas inhalation (Figure 
3 panels b and d). The gas order for this participant was 21% oxygen (Figure 3 top 
panels) followed by 60% oxygen (Figure 3 bottom panels). The QUEST output shows 
the convergence of the procedure towards a final threshold which is the mode of the 
final probability density function.  
[Location of Figure 3] 
The scatter plot in Figure 4, panel A, shows the difference in scotopic threshold 
between hyperoxic and normoxic gas conditions for each individual in the AMD group 
(a) and control group (b). It can be seen that the proportion of individuals showing a 
reduced threshold when breathing 60% oxygen was equivalent between groups. 
Approximately half of each group showed an increase in threshold, and half showed a 
decrease under the hyperoxic gas condition.   
 [Location of Figure 4.] 
Figure 5, panel A, shows the group mean scotopic thresholds for controls and people 
with AMD under hyperoxic and normoxic conditions. There was no statistically 
significant difference between the scotopic thresholds when breathing 21% and 60% 
oxygen for the AMD group (-3.89 log cd/m2 ±0.31SD vs. -3.89 log cd/m2 ±0.30SD; 
paired t-test, P= 0.976), or the control group (-3.95±0.38 SD log cd/m2 vs. -4.01±0.27SD 
log cd/m2; paired t test, P=0.249). There was no statistically significant difference in 
scotopic thresholds between the AMD and control groups when breathing 60% 
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oxygen (independent samples t- test; P=0.31), or 21% oxygen (independent samples 
t- test; P=0.702). There was no statistically significant difference in the change in 
scotopic thresholds from the 21% to the 60% oxygen condition between the two 
participant groups (0.002 log cd/m2 ±0.17SD vs. 0.06 log cd/m2±0.17SD; Mann-
Whitney; P=0.413). There was also no statistically significant difference in the scotopic 
thresholds between the first and second gases across the whole dataset (independent 
t test; P= 0.61).  
 [Location of Figure 5] 
Hypoxia and scotopic thresholds 
SpO2 results 
Figure 2 (panel B) shows the mean SpO2 levels per minute for the AMD and control 
participants, with confidence intervals. There was a statistically significant decrease 
in SpO2 in the final 5 minutes when breathing the hypoxic 14% oxygen gas compared 
to the normoxic 21% oxygen gas in people with early AMD (Wilcoxon signed rank 
P=<0.0001) and in the control group (Wilcoxon signed rank p<0.0001). The median 
(interquartile range) SpO2 under normoxic conditions was 97% (95%-99%) in the 
participants with AMD, and 98% (97%-99%) in the control group (averaged over the 
last 5 minutes of breathing each gas type). This was statistically significant (Mann-
Whitney P=<0.005). The median SpO2 under hypoxic conditions was 93% (90%-96%) 
in the participants with AMD, and 94% (90%-98%) in the control group. This was also 
statistically significant (Mann-Whitney; p<0.0001) 
Hypoxia and scotopic threshold results 
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Scotopic threshold data were analysed for 33 out of 35 participants, as one participant 
(015) did not proceed to the main trial after failing the requirement for the scotopic 
threshold from each of the practice trials to be within one standard deviation of each 
other. The data for one control participant (022) had to be removed from analysis due 
an abnormal OCT indicating a pre-existing ocular condition. Figure 4, panel B shows a 
scatter plot of change in scotopic thresholds for all individuals within the control and 
AMD groups. Again, there was a similar proportion of individuals showing an increase 
in threshold when breathing 14% oxygen, as there was showing a decrease in 
threshold compared to medical air.  
Figure 5 panel B shows the group mean thresholds for each participant group, under 
each gas condition, with 95% confidence intervals. There was no significant 
difference in mean scotopic thresholds when breathing 14% oxygen compared to 
when breathing 21% oxygen within the AMD group (-4.02 log cd/m2 ± 0.11 vs -4.00 
log cd/m2 ± 0.07; paired t-test, P=0.781) or the control group (-4.14 log 
cd/m2±0.09SD vs. -4.14 log cd/m2 ±0.10; paired t-test, P= 0.950). There was also no 
significant difference in the change in thresholds under different gas conditions 
between AMD and control groups (0.03 log cd/m2 IQR 0.13 vs. -0.02 log cd/m2 IQR 
0.12; Mann-Whitney, P= 0.509). Between groups, there was no statistically 
significant difference in mean scotopic threshold between the two groups when 
breathing 14% oxygen (independent samples t test, P= 0.130). There was, however, a 
statistically significant difference in mean scotopic threshold between the two 
groups when breathing 21% oxygen (independent samples t-test, p=0.049) but not 
when breathing 14% oxygen (independent samples t test, p= 0.130), with the AMD 
group showing a significantly higher threshold than the control group under 
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normoxic conditions.  Finally, there was no effect of the order of presented gas 
(paired samples t-test, P=0.196). 
Discussion 
This is the first study to investigate the effect of variable oxygen levels on scotopic 
thresholds in people with AMD. Contrary to the initial hypotheses, there was no 
evidence that breathing 14% or 60% oxygen significantly altered scotopic thresholds 
in those with early to intermediate AMD or in controls, therefore the scotopic 
thresholds of participants with AMD were not affected differently to control 
participants by breathing different oxygen concentrations.  
One possible conclusion of this study is that hypoxia is not responsible for the 
functional deficit seen in early AMD. However, there are other experimental factors 
which may have contributed to this finding. One explanation for the lack of effect of 
breathing 60% oxygen on scotopic thresholds in participants with early AMD is that, 
due to the eligibility criteria for the study which excluded individuals with existing lung 
conditions, no participants in the study were systemically hypoxic i.e. both groups 
showed a mean SpO2 in excess of 97% when breathing 21% oxygen. Therefore, mean 
SpO2 was close to saturation in both groups under the medical air condition, and any 
increase in mean SpO2 attributable to breathing 60% oxygen was limited by the ceiling 
effect to only 1-2%. As the accuracy of the pulse oximeter, according to the 
manufacturer’s guidelines, is +/- 2% of the reading given (Contec, CMS-50E User 
manual), the statistically significant change in oxygen saturation induced by the 
hyperoxic gas condition was within the measurement error of the machine. However, 
SpO2 is an indirect measure of the proportion of haemoglobin bound to oxygen. The 
 15 
oxygen tension in the choroid and blood plasma was not measured directly in this 
study. This is relevant as retinal oxygen tension has been shown to be markedly 
elevated in systemic hyperoxia even in conditions of near blood oxygen saturation 36. 
Tissue oxygen saturation in the outer retina is particularly sensitive to changes in 
inspired oxygen levels as the choroidal circulation does not autoregulate and there is 
no change in choroidal resistance in response to the metabolic demands of the retina, 
or as a consequence of hypoxia or hyperoxia 11,36.  
It is also possible that, despite the near 100% SpO2 under normal breathing conditions, 
structural changes to the subretinal structures cause a localized reduction in oxygen 
supply to the photoreceptors which is not reversible by the inhalation of 
supplementary oxygen in an individual who is not systemically hypoxic. For example, 
according to Fick’s law 7, age-related thickening of Bruch’s membrane 12 as well as the 
formation of basal linear deposits associated with AMD 13,14, will lead to reduced 
oxygen flux to the outer retina as a result of the increased diffusion path.  The 
decreased choroidal blood flow 8, choriocapillaris drop out 9, and changes in choroidal 
vascularity index 10 associated with AMD may also exacerbate localized hypoxia of the 
outer retina.  
Another important factor to consider when interpreting these results is that there 
was no statistically significant difference in scotopic thresholds between the early 
AMD and control groups when breathing 21% oxygen in the hyperoxia study. This is 
in contrast to previous work which has found evidence that scotopic thresholds are 
higher in participants with AMD when compared to age-matched controls 21,22,37-40. 
There are several possible explanations for this discrepancy. Firstly, our group of 
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participants with early AMD included individuals at an earlier stage of the disease 
than those included in previous studies. Notably, participants with late stage AMD 
were included by Brown et al. 40 and Owsley et al.22,37 which may have resulted in 
increased scotopic thresholds in their cohort. Further analysis of the data of Owsley 
et al. 37 comparing only the participant group with early AMD to the control group 
(by calculating the 95% confidence interval), demonstrated no significant difference 
in scotopic thresholds between the two groups. It is also possible that the lack of a 
significant elevation in threshold in the current study was attributable to the large 
annular stimulus used. Owsley et al. 21,22, 37 sampled the retina at a similar distance 
from the fovea (10-12° in the inferior visual field) but used a spot stimulus (1.7° 
diameter). The larger area covered by the annular stimulus will have resulted in a 
greater level of spatial summation of rod responses. This has the benefit of reducing 
variability in thresholds where the disease being investigated is characterized by 
localised abnormalities (i.e. it is heterogeneous), however, it does mean that the 
deficit measured could be reduced by allowing healthier regions of the retina to 
compensate for localised areas of abnormality. Finally, it is worth noting that the 
mean threshold of the AMD group was marginally higher than that of the control 
group under normoxic conditions (see Figure 5), but that this difference failed to 
reach statistical significance. In the second part of the study, evaluating the effect of 
systemic hypoxia on thresholds, a small but significant difference was seen between 
AMD and control groups under the 21% oxygen condition. As this second study had a 
larger sample size, it is possible that the hyperoxia study was insufficiently powered 
to detect the small deficit in threshold present in the AMD group. The relevance of 
the lack of elevated scotopic thresholds in the AMD group of the hyperoxia study is 
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that it is unlikely that hyperoxia will be found to reduce thresholds which are not 
significantly elevated in the first place, regardless of whether hypoxia is a factor in 
the disease pathogenesis.  
Another explanation for the lack of effect of either gas condition on thresholds could 
be that the 10 minute periods of hyperoxia and hypoxia were insufficient to induce 
sufficient localized retinal changes in oxygenation to affect retinal function. This 
would also explain the finding that hyperoxia and hypoxia did not alter scotopic 
thresholds in older participants with healthy retinas. Whilst this is in agreement with 
literature on the effect of systemic hyperoxia on scotopic thresholds 26, it is in 
contrast to other previous hypoxia studies which have suggested that hypoxia raises 
thresholds in normal participants 25,41-45. However, in earlier studies the oxygen 
concentration supplied to create a hypoxic episode was lower than that used in this 
study 25,42,44,45, whilst in other studies which used a similar level of oxygen 27,35, the 
duration of breathing the air was longer. Preliminary studies by our lab found that 
SpO2  stabilised after 8-11mins of breathing air with an altered oxygen concentration. 
This is illustrated by the data in figure 2, in which a plateau in SpO2 is demonstrated 
within the 10 minute timeframe of the experiment. The levels of SpO2 achieved were 
also consistent with those reported by previous studies using a 14% oxygen test gas 
with a longer period of pre-adaptation (15 minutes), suggesting that the test 
duration was sufficient to reach an equilibrium of SpO2 27,35. However, given the 
widespread use of longer adaptation times in other studies investigating the effect of 
systemic periods of hyperoxia and hypoxia 25,27,35,42,44,45, future work in this area may 
benefit from allowing a prolonged period of adaptation (in excess of 15 minutes) to 
the altered oxygen conditions to ensure that respiratory equilibrium has been 
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achieved. Whilst a greater level of hypoxia could also have been induced by 
breathing air with a lower oxygen concentration, the 14% oxygen used to induce 
hypoxia was in line with other studies (e.g. Connolly et al.  25, 40), and ethical 
considerations prevented us from taking this approach. 
In this study, only one aspect of visual function was assessed, scotopic thresholds. It 
is possible that other aspects of visual function may have shown a greater effect of 
changing systemic oxygenation. For example, rates of dark adaptation 25,26, colour 
vision 24 and contrast sensitivity 35 have been shown to be affected in healthy 
controls when breathing air with a reduced oxygen concentration. In this study, 
scotopic function was chosen for evaluation as hypoxia is hypothesized to be at its 
greatest in the outer retina under scotopic conditions, when the rod current is active 
11. Hence, it is unlikely that a greater effect would have been observed under 
photopic or mesopic conditions. However, it may be of particular interest in future 
work to evaluate the effect of systemic hypoxia on rates of dark adaptation. The 
kinetics of dark adaptation have been shown to be affected differentially to scotopic 
thresholds by early AMD, and are likely to reflect a different aspect of the disease 
mechanism 21,37. It is possible that elevated scotopic thresholds reflect the loss of rod 
photoreceptors reported to occur in early AMD 46, and so may not be reversible by 
short term manipulation of blood oxygenation. Delays in dark adaptation associated 
with AMD have previously been shown to be mitigated by vitamin A 
supplementation 47, suggesting that they may be more amenable to reversal by 
manipulation of physiological conditions.  
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It might be argued that this study was limited by the exclusion of individuals with 
advanced nAMD in the test eye. The evidence of molecular markers of hypoxia such 
as VEGF and hypoxia inducible factor is much stronger in these individuals than in 
those with early/intermediate AMD 15,48-50. Thus, it may follow that the likelihood of 
finding a significant effect in this study would be increased by the inclusion of 
participants with nAMD. One reason for focusing on people with early and 
intermediate AMD was that understanding the mechanisms which drive the early 
stages of AMD is likely to have more meaningful treatment implications. Mitigation 
of the factors causing early AMD to advance may bring about delayed progression to 
late stage disease. Once choroidal neovascularisation has occurred, substantial and 
irreversible structural changes to the macula have already taken place. Another 
rationale is that the changes in visual function which have occurred in people with 
advanced AMD are less likely to be reversible by changes in systemic oxygenation 
than the milder functional losses associated with early stage disease. In this study, 
the majority of eyes with early or intermediate AMD (18/22) had a status in the 
fellow eye which put them at a relatively high risk of progression to a more advanced 
disease state in the test eye 34 (see Table 1). In all cases, this was due to neovascular 
changes in the fellow eye. Other studies have tested the non-neovascular eye of 
participants with unilateral nAMD as a means of determining the effects of a more 
severe subtype of early/intermediate AMD on visual function 51-55. The lack of 
evidence of hypoxia in this cohort is, perhaps, of more clinical significance than a 
similar finding in individuals with bilateral early changes would be as it suggests that 
even in a more severe subtype of early AMD there is no clear evidence of systemic 
hypoxia. However, it remains the case that evaluation of the effects of hyperoxia and 
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hypoxia on individuals with nAMD may produce a different outcome and would be of 
interest in future work. 
A possible limitation of this study was the use of a fixed termination after 40 
presentations rather than a dynamic termination in the QUEST procedure, used due 
time constraints for safety. Studies comparing dynamic and fixed stopping criterion 
in Bayesian procedures concluded that there was little evidence to recommend the 
use of the dynamic over a fixed criterion 56. An additional limitation was that the 
effects of breathing reduced levels of oxygen were measured by changes in SpO2, 
which is a systemic measure. It may be that it takes longer to create localised retinal 
hypoxia than it does to induce systemic changes. A further limitation of this study 
was the relatively small sample size which introduces the possibility of a type II error 
in the negative findings of this study. 
In conclusion, this study did not provide evidence to the support the hypothesis that 
hypoxia is responsible for functional deficits in early AMD, but did not exclude the 
possibility that localised retinal hypoxia may be a contributory factor. The 
understanding of the aetiology of AMD is key in the development of new treatments. 
If hypoxia plays a part in the pathogenesis of early AMD then treatments aimed at 
reducing hypoxia could have therapeutic value.  
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Table 1 Characteristics of participants with early AMD. AMD status score relates to the AREDS 





Figure 1. Timeline of experimental protocol. This was the same for both the hyperoxia 
and the hypoxia study. ‘Gas 1’ and ‘gas 2’ refer to the two gases used in random order 
in each visit. One of these was always medical air. 
 
Figure 2. Mean SpO2 results per minute for each group (controls and AMD, with 95% 
confidence intervals). Results are compared under conditions of 60% oxygen 
(diamonds) vs. 21% oxygen (squares) (panel A a,b) and 14% oxygen (diamonds) vs. 
21% oxygen (squares) (panel B a,b). Both experimental gases has a significant effect 
on group averaged SpO2 data, with SpO2 readings stabilizing after 5 minutes of 
breathing the gas.  
 
Figure 3. Sample scotopic threshold QUEST output from one individual with standard 
deviations (a,c), with corresponding SpO2 recordings (b,d) during data collection. Top 
panels show data when breathing 21% oxygen and bottom panels when breathing 
60% oxygen. All data collected from control participant 017. 
 
Figure 4. Scatter plot showing change in scotopic threshold under different gas 
conditions for all participants. Panel A shows the difference in thresholds when 
breathing 60% oxygen compared to breathing 21% oxygen. Panel B shows the 
difference in thresholds when breathing 14% oxygen compared to breathing 21% 
 31 
oxygen. A negative value indicates a lower threshold for the experimental gas than 
the medical air.  
 
Figure 5 Group mean scotopic thresholds with 95% confidence intervals for the AMD 
group (a) and for the control group (b) under 21% and 60% oxygen conditions (Panel 
A) and 21% and 14% conditions (Panel B, a and b). There were no significant 
differences in threshold between gas conditions for either group.  
 
 
 
 
